StockNews.com upgraded shares of Wyndham Hotels & Resorts (NYSE:WH – Free Report) from a sell rating to a hold rating in a research note issued to investors on Friday morning.
A number of other research firms have also recently commented on WH. Stifel Nicolaus upped their target price on shares of Wyndham Hotels & Resorts from $91.00 to $92.00 and gave the company a “buy” rating in a research report on Thursday, October 24th. Truist Financial upped their price objective on shares of Wyndham Hotels & Resorts from $103.00 to $105.00 and gave the stock a “buy” rating in a report on Friday, October 25th. The Goldman Sachs Group initiated coverage on Wyndham Hotels & Resorts in a research report on Wednesday, September 18th. They issued a “buy” rating and a $96.00 target price on the stock. Barclays lifted their price objective on Wyndham Hotels & Resorts from $90.00 to $100.00 and gave the company an “overweight” rating in a research note on Friday, October 25th. Finally, Robert W. Baird raised their target price on Wyndham Hotels & Resorts from $92.00 to $97.00 and gave the company an “outperform” rating in a report on Friday, October 25th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $95.00.
View Our Latest Analysis on WH
Wyndham Hotels & Resorts Stock Up 0.8 %
Wyndham Hotels & Resorts (NYSE:WH – Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The company reported $1.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.38 by $0.01. Wyndham Hotels & Resorts had a net margin of 18.29% and a return on equity of 51.79%. The business had revenue of $396.00 million during the quarter, compared to the consensus estimate of $408.32 million. During the same quarter last year, the firm earned $1.31 EPS. The business’s revenue was down 1.5% compared to the same quarter last year. On average, research analysts expect that Wyndham Hotels & Resorts will post 4.3 earnings per share for the current year.
Wyndham Hotels & Resorts Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 27th. Stockholders of record on Friday, September 13th were given a dividend of $0.38 per share. The ex-dividend date was Friday, September 13th. This represents a $1.52 annualized dividend and a dividend yield of 1.71%. Wyndham Hotels & Resorts’s dividend payout ratio (DPR) is currently 48.25%.
Insider Activity at Wyndham Hotels & Resorts
In other Wyndham Hotels & Resorts news, Director Stephen P. Holmes sold 80,000 shares of the firm’s stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $91.01, for a total transaction of $7,280,800.00. Following the sale, the director now owns 366,371 shares of the company’s stock, valued at approximately $33,343,424.71. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Wyndham Hotels & Resorts news, insider Monica Melancon sold 5,040 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $77.66, for a total transaction of $391,406.40. Following the transaction, the insider now directly owns 10,606 shares of the company’s stock, valued at approximately $823,661.96. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Stephen P. Holmes sold 80,000 shares of the company’s stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $91.01, for a total transaction of $7,280,800.00. Following the completion of the sale, the director now directly owns 366,371 shares of the company’s stock, valued at $33,343,424.71. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 100,040 shares of company stock valued at $9,022,056 over the last quarter. 2.79% of the stock is owned by insiders.
Hedge Funds Weigh In On Wyndham Hotels & Resorts
Institutional investors have recently added to or reduced their stakes in the stock. Assetmark Inc. acquired a new position in shares of Wyndham Hotels & Resorts during the third quarter worth about $30,000. GAMMA Investing LLC lifted its holdings in shares of Wyndham Hotels & Resorts by 80.9% in the 2nd quarter. GAMMA Investing LLC now owns 463 shares of the company’s stock valued at $34,000 after buying an additional 207 shares during the period. Concord Wealth Partners boosted its stake in shares of Wyndham Hotels & Resorts by 115.5% in the third quarter. Concord Wealth Partners now owns 543 shares of the company’s stock valued at $42,000 after buying an additional 291 shares in the last quarter. Blue Trust Inc. grew its holdings in Wyndham Hotels & Resorts by 1,245.1% during the second quarter. Blue Trust Inc. now owns 686 shares of the company’s stock worth $53,000 after acquiring an additional 635 shares during the period. Finally, Family Firm Inc. purchased a new position in Wyndham Hotels & Resorts in the second quarter worth $67,000. Institutional investors and hedge funds own 93.46% of the company’s stock.
Wyndham Hotels & Resorts Company Profile
Wyndham Hotels & Resorts, Inc operates as a hotel franchisor in the United States and internationally. It operates through Hotel Franchising and Hotel Management segments. The Hotel Franchising segment licenses its lodging brands and provides related services to third-party hotel owners and others.
Read More
- Five stocks we like better than Wyndham Hotels & Resorts
- Quiet Period Expirations Explained
- Intel: Is Now the Time to Be Brave?Â
- Dividend Payout Ratio Calculator
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- The 3 Best Blue-Chip Stocks to Buy Now
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Wyndham Hotels & Resorts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wyndham Hotels & Resorts and related companies with MarketBeat.com's FREE daily email newsletter.